Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study
Crossref DOI link: https://doi.org/10.1007/s10637-015-0246-2
Published Online: 2015-05-08
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pedersen, Katrina S. http://orcid.org/0000-0003-2793-6901
Kim, George P.
Foster, Nathan R.
Wang-Gillam, Andrea
Erlichman, Charles
McWilliams, Robert R.
Text and Data Mining valid from 2015-05-08
Version of Record valid from 2015-05-08
Article History
Received: 15 April 2015
Accepted: 28 April 2015
First Online: 8 May 2015